ArticleBMC nephrology2026
Multiparametric MRI as predictors for evaluating renal ischemia reperfusion injury and protective effect of Mito-TEMPO in rat model.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundWe aimed to evaluate multiparametric magnetic resonance imaging (MRI), including blood oxygen level dependent (BOLD), arterial spin labeling (ASL), and intravoxel incoherent motion (IVIM) for noninvasively monitoring acute kidney injury (AKI) to acute kidney disease (AKD) progression following renal ischemia reperfusion injury (IRI) and the subsequent response to Mito-TEMPO (MT) therapy.
methodsPhase 1: 42 Sprague Dawley (SD) rats (36 IRI and 6 control). Phase 2: 144 SD rats (IRI/control + MT treatment/saline, 36 per group). IRI group: left renal ischemia reperfusion procedures, control group: sham abdominal surgery. Animals underwent MRI scanning to obtain effective transverse relaxation rate (R2*), renal blood flow (RBF), apparent diffusion coefficient (ADC), pure molecular diffusion (D), perfusion-related diffusion (D*), and perfusion fraction (f) values of kidney. After sacrifice, serological and histological analysis were performed.
resultsAll MRI parameters (R2*, RBF, ADC, D*, D, f) showed significant, time-dependent alterations following IRI compared to controls. These changes were effectively reversed by MT treatment, with most parameters recovering to near-baseline levels.
conclusionBOLD, ASL, and IVIM can be used as noninvasive radiologic markers for detecting the progression from renal IRI to AKI-AKD and recovery after MT treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.